ArticleFrontiers in cardiovascular medicine2022

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients.

Wei-Fang Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.